Quantitation of HIV-1 DNA with a sensitive TaqMan assay that has broad subtype specificity

Journal of Virological Methods

Volumn 187, Issue 1, 2013, Pages 94-102

  van der Sluis, Renée M ^a   van Montfort, Thijs ^a   Centlivre, Mireille ^a   Schopman, Nick C T ^a   Cornelissen, Marion ^a   Sanders, Rogier W ^a,b   Berkhout, Ben ^a   Jeeninga, Rienk E ^a   Paxton, William A ^a   Pollakis, Georgios ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

DNA quantitation; HIV 1; LTR; Subtypes

Indexed keywords

GENOMIC DNA; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; GENE DOSAGE; GENETIC CONSERVATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY DEVICE; LONG TERMINAL REPEAT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION; VIRUS LOAD;

CELL LINE; DNA PRIMERS; DNA, VIRAL; GENETIC VARIATION; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TAQ POLYMERASE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871729888     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.09.019     Document Type: Article

References (48)

1. 2011a. http://eu.idtdna.com/scitools/scitools.aspx.
2. 2011b. http://mfold.rna.albany.edu/.
3. 2011c. http://www.hiv.lanl.gov/components/sequence/HIV.
4. 2011d. http://www.hiv.lanl.gov/content/sequence/NEWALIGN/align.html.
5. Abbink T.E., Berkhout B. HIV-1 reverse transcription initiation: a potential target for novel antivirals?. Virus Res. 2008, 134:4-18.
6. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 1990, 28:495-503.
7. Buonaguro L., Tagliamonte M., Tornesello M.L., Pilotti E., Casoli C., Lazzarin A., Tambussi G., Ciccozzi M., Rezza G., Buonaguro F.M., Italian Concerted Action on PHI Treatment Screening of HIV-1 isolates by reverse heteroduplex mobility assay and identification of non-B subtypes in Italy. J. Acquir. Immune Defic. Syndr. 2004, 37:1295-1306.
8. Buonaguro L., Tornesello M.L., Buonaguro F.M. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J. Virol. 2007, 81:10209-10219.
9. Centlivre M., Legrand N., Steingrover R., van der Sluis R., Grijsen M.L., Bakker M., Jurriaans S., Berkhout B., Paxton W.A., Prins J.M., Pollakis G. Altered dynamics and differential infection profiles of lymphoid and myeloid cell subsets during acute and chronic HIV-1 infection. J. Leukoc. Biol. 2011, 89:785-795.
10. Ciccozzi M., Montieri S., Salemi M., De Oliveira T., Dorrucci M., Sinicco A., De Luca A., Giuliani M., Balotta C., Rezza G. An outbreak of HIV-1 subtype G among Italian injecting drug users. AIDS 2007, 21:1213-1215.
11. Das A.T., Zhou X., Vink M., Klaver B., Verhoef K., Marzio G., Berkhout B. Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J. Biol. Chem. 2004, 279:18776-18782.
12. Davis C., Berry N., Heath A., Holmes H. An international collaborative study to establish a replacement World Health Organization International Standard for human immunodeficiency virus 1 RNA nucleic acid assays. Vox Sang. 2008, 95:218-225.
13. de Baar M.P., van Dooren M.W., de Rooij E., Bakker M., van Gemen B., Goudsmit J., de Ronde A. Single rapid real-time monitored isothermal RNA amplification assay for quantitation of human immunodeficiency virus type 1 isolates from groups M, N, and O. J. Clin. Microbiol. 2001, 39:1378-1384.
14. De Rossi A., Zanchetta M., Vitone F., Antonelli G., Bagnarelli P., Buonaguro L., Capobianchi M.R., Clementi M., Abbate I., Canducci F., Monachetti A., Riva E., Rozera G., Scagnolari C., Tagliamonte M., Re M.C., SIVIM (Italian Society of Medical Virology) Group Quantitative HIV-1 proviral DNA detection: a multicentre analysis. New Microbiol. 2010, 33:293-302.
15. Delaugerre C., Charreau I., Braun J., Néré M.L., de Castro N., Yeni P., Ghosn J., Aboulker J.P., Molina J.M., Simon F., ANRS 138 Study Group Time course of total HIV-1 DNA and 2-long-terminal repeat circles in patients with controlled plasma viremia switching to a raltegravir-containing regimen. AIDS 2010, 24:2391-2395.
16. Descamps D., Chaix M.L., Montes B., Pakianather S., Charpentier C., Storto A., Barin F., Dos Santos G., Krivine A., Delaugerre C., Izopet J., Marcelin A.G., Maillard A., Morand-Joubert L., Pallier C., Plantier J.C., Tamalet C., Cottalorda J., Desbois D., Calvez V., Brun-Vezinet F., Masquelier B., Costagliola D., ANRS AC11 Resistance Study Group Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. J. Antimicrob. Chemother. 2010, 65:2620-2627.
17. Djoko C.F., Rimoin A.W., Vidal N., Tamoufe U., Wolfe N.D., Butel C., LeBreton M., Tshala F.M., Kayembe P.K., Muyembe J.J., Edidi-Basepeo S., Pike B.L., Fair J.N., Mbacham W.F., Saylors K.E., Mpoudi-Ngole E., Delaporte E., Grillo M., Peeters M. High HIV type 1 group M pol diversity and low rate of antiretroviral resistance mutations among the uniformed services in Kinshasa, DRC. AIDS Res. Hum. Retroviruses 2010, 27:323-329.
18. Djoko C.F., Wolfe N.D., Vidal N., Tamoufe U., Montavon C., LeBreton M., Pike B.L., Fair J., Mbacham W.F., Benito A., Rimoin A.W., Saylors K., Mpoudi-Ngole E., Grillo M.P., Peeters M. HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea. AIDS Res. Hum. Retroviruses 2010, 26:1027-1031.
19. Drosten C., Panning M., Drexler J.F., Hänsel F., Pedroso C., Yeats J., de Souza, Luna L.K., Samuel M., Liedigk B., Lippert U., Stürmer M., Doerr H.W., Brites C., Preiser W. Ultrasensitive monitoring of HIV-1 viral load by a low-cost real-time reverse transcription-PCR assay with internal control for the 5' long terminal repeat domain. Clin. Chem. 2006, 52:1258-1266.
20. Farnet C.M., Haseltine W.A. Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:4164-4168.
21. Farnet C.M., Haseltine W.A. Circularization of human immunodeficiency virus type 1 DNA in vitro. J. Virol. 1991, 65:6942-6952.
22. Graf E.H., Mexas A.M., Yu J.J., Shaheen F., Liszewski M.K., Di Mascio M., Migueles S.A., Connors M., O'Doherty U. Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off HAART. PLoS Pathog. 2011, 7:e1001300.
23. Hatzakis A.E., Touloumi G., Pantazis N., Anastassopoulou C.G., Katsarou O., Karafoulidou A., Goedert J.J., Kostrikis L.G. Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy. AIDS 2004, 18:2261-2267.
24. Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends Mol. Med. 2012, 18:182-192.
25. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:W13-W23.
26. Jeeninga R.E., Westerhout E.M., van Gerven M.L., Berkhout B. HIV-1 latency in actively dividing human T cell lines. Retrovirology 2008, 5:37.
27. Katsoulidou A., Rokka C., Issaris C., Haida C., Tzannis K., Sypsa V., Detsika M., Paraskevis D., Hatzakis A. Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece. Virol. J. 2011, 8:10.
28. Li P., Ruel T., Fujimoto K., Hatano H., Yukl S., Eller L.A., Liegler T., Kamya M., Gassasira A., Dorsey G., Rosenthal P.J., Havlir D.V., Wong J.K. Novel application of locked nucleic acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. J. Virol. Methods 2010, 170:115-120.
29. Librado P., Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009, 25:1451-1452.
30. Loemba H., Brenner B., Parniak M.A., Ma'ayan S., Spira B., Moisi D., Oliveira M., Detorio M., Wainberg M.A. Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT. Antimicrob. Agents Chemother. 2002, 46:2087-2094.
31. Marzio G., Verhoef K., Vink M., Berkhout B. In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6342-6347.
32. McCutchan F.E. Understanding the genetic diversity of HIV-1. AIDS 2000, 14(Suppl. 3):S31-S44.
33. Michael N.L., Herman S.A., Kwok S., Dreyer K., Wang J., Christopherson C., Spadoro J.P., Young K.K., Polonis V., McCutchan F.E., Carr J., Mascola J.R., Jagodzinski L.L., Robb M.L. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 1999, 37:2557-2563.
34. Morlese J., Teo I.A., Choi J.W., Gazzard B., Shaunak S. Identification of two mutually exclusive groups after long-term monitoring of HIV DNA 2-LTR circle copy number in patients on HAART. AIDS 2003, 17:679-683.
35. Palma A.C., Araújo F., Duque V., Borges F., Paixão M.T., Camacho R., Portuguese SPREAD Network Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect. Genet. Evol. 2007, 7:391-398.
36. Pasternak A.O., Adema K.W., Bakker M., Jurriaans S., Berkhout B., Cornelissen M., Lukashov V.V. Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. J. Clin. Microbiol. 2008, 46:2206-2211.
37. Peeters M. The genetic variability of HIV-1 and its implications. Transfus. Clin. Biol. 2001, 8:222-225.
38. Perrin L., Kaiser L., Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect. Dis. 2003, 3:22-27.
39. Plantier J.C., Leoz M., Dickerson J.E., De Oliveira F., Cordonnier F., Lemée V., Damond F., Robertson D.L., Simon F. A new human immunodeficiency virus derived from gorillas. Nat. Med. 2009, 15:871-872.
40. Pollakis G., Kang S., Kliphuis A., Chalaby M.I., Goudsmit J., Paxton W.A. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization. J. Biol. Chem. 2001, 276:13433-13441.
41. Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., Gao F., Hahn B.H., Kalish M.L., Kuiken C., Learn G.H., Leitner T., McCutchan F., Osmanov S., Peeters M., Pieniazek D., Salminen M., Sharp P.M., Wolinsky S., Korber B. HIV-1 nomenclature proposal. Science 2000, 288:55-56.
42. Simon F., Mauclère P., Roques P., Loussert-Ajaka I., Müller-Trutwin M.C., Saragosti S., Georges-Courbot M.C., Barré-Sinoussi F., Brun-Vézinet F. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 1998, 4:1032-1037.
43. Smith S.D., Shatsky M., Cohen P.S., Warnke R., Link M.P., Glader B.E. Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res. 1984, 44:5657-5660.
44. Ssebugenyi I., Kizza A., Mpoza B., Aluma G., Boaz I., Newell K., Laeyendecker O., Shott J.P., Serwadda D., Reynolds S.J. Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda. Int. J. STD AIDS 2011, 22:373-375.
45. Stevens S.W., Griffith J.D. Human immunodeficiency virus type 1 may preferentially integrate into chromatin occupied by L1Hs repetitive elements. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:5557-5561.
46. van der Sluis R.M., Pollakis G., van Gerven M.L., Berkhout B., Jeeninga R.E. Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter. Retrovirology 2011, 8:73.
47. Westerhout E.M., Vink M., Haasnoot P.C., Das A.T., Berkhout B. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication. Mol. Ther. 2006, 14:268-275.
48. Wu Y. HIV-1 gene expression: lessons from provirus and non-integrated DNA. Retrovirology 2004, 1:13.